organic chemistry on hetero cyclic type

Not a hard requirement at most chemistry journals — J. Med. Chem. and many Letters-format journals don't mandate one — but for a process-development paper it is where the value proposition lives. Your data alone says "this is what we did"; the conclusion says "this is why it matters": overall yield, purity achieved, impurity control, number of steps, cost and scalability, and what the route replaces. If you omit it: The paper reads as unfinished. Process papers are judged on claimed advantage; with no conclusion, a reviewer is left to infer it, and will usually respond with "the authors should add a concluding section summarizing the merits of the route." That is a guaranteed revision request. Editorial triage. Many journals run a completeness check before peer review — abstract, keywords, conclusion, conflict-of-interest, data availability. A missing section is a common cause of return-to-author before the paper ever reaches a reviewer. You lose control of your own claim. Reviewers will then write the take-home message for you in their report, and you'll be answering it rather than stating it. A workable pattern for a process paper, 150–250 words: (1) one sentence restating the route and the key transformations; (2) the quantitative outcome — overall yield, purity, single-impurity limit, melting point; (3) the specific advantages over prior routes — fewer steps, no chromatography, cheaper reagents, plant-compatible operations; (4) one honest limitation and one forward-looking sentence. Acknowledgements This one is conditional, and the condition is funding. If any author was supported by a grant, fellowship, or industry contract, most funders make acknowledgement a term of the award, and journals require it. Omitting it: Breaches the grant agreement — the practical consequence is that the paper cannot be counted as an output of that grant, which affects reporting and future funding. Can trigger a correction after publication, which is more damaging than getting it right the first time. For industry-collaborative work, it is also a courtesy/credit issue for the partner who supplied material or analytical support. If there is genuinely nothing to acknowledge, many journals still want an explicit statement or will accept omission — check the specific journal's author guidelines, because practice varies. What you should also not forget (more commonly missed than the conclusion) Modern journals require these regardless of whether you write a conclusion: Declaration of competing interests — mandatory at essentially every publisher; for an industry process paper this is essential. Author contributions (CRediT) — increasingly mandatory. Data availability statement — mandatory at most publishers now. Funding statement — often a separate field from Acknowledgements. Ethics/safety statement — if hazardous reagents are involved (TMSBr, hydrazine, Grignard, ethyl chloroformate in your routes, for example), a safety note is looked on favourably and occasionally required. One important exception If the document is a patent specification, none of this applies. Patent applications have no conclusion and no acknowledgements — they end with the claims, and adding either would be unusual. So the answer depends on the destination: journal article → write both (conclusion always, acknowledgement if funded); patent → neither; thesis → conclusion mandatory, acknowledgements expected. If you tell me which journal you're targeting, I can tell you exactly which of these are mandatory there and draft the conclusion paragraph from your process data. View all artifacts (19) 19:49 1. Methano... based on this process, please provide an descripition 19:58 WorkBuddy The description is delivered as Loratadine_Process_Description.docx (2,000 words + results table) — written in specification register, so it complements the introduction rather than repeating it. Structure Add to conversation Section Content 1. Technical field Defines the invention in one paragraph: three-stage process, molecular weight 382.88 2. Description of the process Stage 1, Stage 2, Stage 3, Purification 1 and 2 — each as continuous prose with every charge, temperature and hold time 3. Critical process parameters The four variables that decide reproducibility 4. Characterization data Full ¹H NMR, MS and elemental analysis for (a), (b) and loratadine (c) 5. Utility What the route achieves, in one paragraph What the description adds beyond the introduction — Section 3 identifies the four parameters that actually govern the process: Water, at both ends: anhydrous THF in Stage 1, and the ketone dried below 0.5% because residual moisture consumes the H₂SO₄/H₃BO₃ medium in Stage 2. Addition temperature in Stage 1 — the piperidine must go in at 55–60 °C after iodine initiation; adding cold leaves magnesium unconsumed and the nitrile addition then stalls. The 9-hour hold in Stage 2, which is a minimum even when the HPLC limit on unreacted (a) is met early, because residual ketone survives the crystallizations. The crystallization cooling profile (0–5 °C over 3–4 h), which sets both recovery and the single-impurity figure. Three data corrections I made — all disclosed in a note at the end of the document MS ion labels: the source gives "345 (M+3)", "327 (M+3)", "385 (M+3)". A single chlorine requires an M / M+2 pair at roughly 3:1, so I used 343/345, 325/327 and 383/385, keeping your intensity order. Worth checking against the raw spectra. Loratadine 2.26 ppm → 7.26 ppm (the signal sits between 7.23 and 7.65, so 2.26 cannot be right). “1.65 Hz” restored after the H₄ coupling, where "Hz" was missing. If any of these were genuine values rather than transcription slips, tell me and I'll revert them.